Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update
WOBURN, Mass. , March 11, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell technology commercial strategy and pipeline. An estimated 100 million US adults have chronic pain. People with chronic pain may also have low quality sleep, anxiety, depression,
View HTML
Toggle Summary NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®
WOBURN, Mass. , March 05, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the recent publication of three additional DPNCheck clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of peripheral
View HTML
Toggle Summary NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting
WOBURN, Mass. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36 th Annual Meeting to be held February 26 - March 1 in National Harbor , MD.
View HTML
Toggle Summary NeuroMetrix Reports Q4 and Full Year 2019 Financial Results
WOBURN, Mass. , Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported financial and business highlights for the quarter and year ended December 31, 2019 . The Company develops and commercializes diagnostic and therapeutic neurostimulation-based medical devices.
View HTML
Toggle Summary NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020
WOBURN, Mass. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time . Internal scheduling conflicts caused the delay of two business days.
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call
WOBURN, Mass. , Jan. 17, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 fourth quarter and full year financial results before the opening of the market on Thursday, January 23, 2020 . The Company will host a conference call at 8:00 a.m.,
View HTML
Toggle Summary NeuroMetrix Announces One-for-Ten Reverse Split
Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on November 19, 2019 WOBURN, Mass. , Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock.
View HTML
Toggle Summary NeuroMetrix Reports Q3 2019 Financial Results
WOBURN, Mass. , Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported financial and business highlights for the quarter ended September 30, 2019 . The Company develops and commercializes products for the chronic pain and diabetes markets that utilize neurostimulation
View HTML
Toggle Summary NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
WOBURN, Mass. , Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announced important updates to its Quell ® 2.0 commercial strategy.  This novel wearable device
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call
WOBURN, Mass. , Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on Thursday, October 17, 2019 . The Company will host a conference call at 8:00 a.m., Eastern Time on
View HTML